Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07100626 · ClinicalTrials.gov registry record · NA
In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization
A NA study of Dental Caries, sponsored by Incisive Technologies Pty.
- Active
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT07100626: Active NA study of Dental Caries, sponsored by Incisive Technologies Pty.
NCT07100626 is a NA study of Dental Caries that is active but no longer recruiting, run by Incisive Technologies Pty. The registered enrollment target is 12 participants, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07100626, a NA study of Dental Caries, is active but no longer recruiting, sponsored by Incisive Technologies Pty.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to answer are: * Can BlueCheck® reliably detect early carious lesions with high sensitivity and specificity? * Does BlueCheck® visually reflect changes in remineralized enamel lesions? BlueCheck® results will be compared against standard diagnostic methods (e.g., Nyvad criteria, Diagnodent readings, surface microhardness) to see if BlueCheck® provides an objective, accurate, and visual method of detecting and monitoring early-stage caries. Participants will: * Wear a modified lower partial denture with four mounted enamel specimens for 28 days. * Use only the study-provided fluoride containing toothpaste * Attend weekly clinic visits for removal and laboratory analysis of one enamel specimen per week. * Undergo regular oral health checks and provide diary entries tracking brushing and any adverse events.
Primary Outcome
BlueCheck will be applied to the early stage enamel carious lesions and visually assessed whether they are highlighted blue
Conditions Studied
Interventions
- DEVICE BlueCheck
Study Locations (1)
Indiana
- Oral Health Research Institute - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2025-09-24 |
| Est. Completion | 2026-01 |
| Phase | NA |
What the registry record for NCT07100626 still lists
NCT07100626 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which BlueCheck is the first listed.
NCT07100626 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT07100626 about?
NCT07100626 is a clinical study titled "In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization". The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to...
What is the current status of trial NCT07100626?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-09-24. Estimated completion is 2026-01.
What conditions does trial NCT07100626 study?
This clinical trial studies the following conditions: Dental Caries.
What interventions are being tested in trial NCT07100626?
The interventions under investigation include: BlueCheck (DEVICE).
Who is sponsoring clinical trial NCT07100626?
This trial is sponsored by Incisive Technologies Pty, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07100626 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07100626's enrollment target sits among peer trials
12 30th of 30 the lowest of 30 other Dental Caries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Dental Caries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparing Stainless Steel Crowns with Prefabricated Resin Crowns in Primary Molar Teeth
RECRUITING · NA
-
LT Comparative Effectiveness of 2 Caries Treatments
RECRUITING · NA
-
Advancing Water Security: A Community Participatory School-Based Hydration Intervention
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries
RECRUITING · NA
-
Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI